The Gladstone Foundation is a nonprofit organization that provides financial and advisory support to Gladstone Institutes. Established in 2011, this volunteer organization is composed of dedicated leaders who understand that the search for global cures must begin with deep biological knowledge and research.
Gladstone Foundation Board of Directors
Chairman
William H. Younger, Jr.
Managing Director, Sutter Hill Ventures
Vice Chair
Stasia A. Obremskey
Strategy Director, Contraceptive Technology Development, Rhia Ventures
Board Members
Chris Boskin
Media Consultant
Marianne De Backer, PhD, MBA
Head of Pharmaceuticals Business Development and Licensing, Bayer
Paul C. Edwards
Edwards Partners
Tom Furst
Former CFO, SRI International
Linda Grais, MD, JD
Former President and CEO, Ocera Therapeutics
Erin Hoffmann
President and Co-Founder at Additional Ventures
Perry Karsen
Former CEO, Celgene Cellular Therapeutics and EVP, Chief Operations Officer of Celgene Corporation
Laura S. Lehman, PhD
Vice President, Research Strategy and Portfolio Management, Gilead Sciences
Gary Morgenthaler
Partner, Morgenthaler Ventures
Steve Richardson
CEO, Alexandria Real Estate
Douglas G. Scrivner
Retired General Counsel, Accenture
Deepak Srivastava, MD
President, Gladstone Institutes
Director, Roddenberry Stem Cell Center
Gary T. Steele
Retired Chairman, President, and CEO, Landec
James B. Tananbaum, MD
Founder, CEO, and Managing Director, Foresite Capital Management
R. Sanders Williams, MD
President Emeritus, Gladstone Institutes
Sharon Winslow
Attorney
Board Officers
Chris Nicholson
Secretary
Michelle Sibly
Treasurer
Robert Wicks
CEO
